LSBio
IHC-plus™ EPHA10 / EPH Receptor A10 Antibody (clone 2E8)

Anti-EPHA10 / EPH Receptor A10 antibody IHC staining of human testis. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody dilution 1:50.

IHC-plus™ EPHA10 / EPH Receptor A10 Antibody (clone 2E8)

Primary AntibodyLSBio Guarantee
Antibody:Mouse Monoclonal
Applications:Enzyme-Linked Immunosorbent Assay, Immunohistochemistry (general), Immunohistochemistry, Paraffin, Western Blot
Reactivity:Human
Format:Liquid
See all EPHA10 / EPH Receptor A10 antibodies →
$383.00each
Catalog Number: LS-B10732-50

For bulk orders or custom formulations:

Request a Quote

Overview

Description
EPH Receptor A10 antibody LS-B10732 is an unconjugated mouse monoclonal antibody to human EPH Receptor A10 (EPHA10). Validated for ELISA, IHC and WB. Tested on 20 paraffin-embedded human tissues. Cited in 1 publication.
Application
ELISA, IHC, IHC-P, WB
Reactivity
Hu
Intended Use
Research Use Only
Guarantees
This product carries the LSBio 100% Guarantee.
Category
Antibodies > Primary Antibodies > Monoclonal Antibodies
Alternative Names
EPHA10 | Ephrin type-A receptor 10 | EPH receptor A10 | EphA10s protein
Recommended Dilution: ELISA
1:10000
Recommended Dilution: IHC-P
1:50
Recommended Dilution: WB
1:100 - 1:500
UniProt Number
Q5JZY3
SwissProt
Q5JZY3

Target

Target
EPHA10 / EPH Receptor A10
Antigen Species
Human
Specificity
Human
Epitope
Human
Gene Name
EPHA10

Antibody

Host Species
Mouse
Clonality
Monoclonal
Clone
2E8
Isotype
IgG2a
Origin Species
Human

Immunogen

Immunogen
Purified recombinant fragment of human Epha10 expressed in E. Coli.
Immunogen Type
Recombinant Protein Fragment

Format

Conjugate/Label
Unconjugated
Format
Liquid
Formulation
Ascitic fluid, 0.03% sodium azide
Volume
50 Microliter
Animal Free
No
Carrier-Free
Yes
Preservative
Yes
Purification Method
Unpurified (Serum / Ascites / Supernatant)

Storage & Handling

Storage Conditions
Short term: store at 4°C. Long term: store at -20°C.
Juxtacrine Signaling Inhibits Antitumor Immunity by Upregulating PD-L1 Expression. Wen-Hao Yang, Jong-Ho Cha, Weiya Xia, Heng-Huan Lee, Li-Chuan Chan, Ying-Nai Wang, Jennifer L Hsu, Guoxin Ren, Mien-Chie Hung. Cancer research. 2018 July;78:3761-3768. PubMed: 29789418 PMC: PMC6050079

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.